1. Barel M, Charriaut C, Frade R (1981) Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line ( Raji ). FEBS Letters 136: 111–114.
2. Barel M, Vazquez A, Charriaut C, Aufredou MT, Galanaud P, Frade R. (1986) Gpl40, the C3d/EBV receptor (CR2) is phosphorylated upon in vitro activation of human peripheral B lymphocytes. FEBS Letters. 197: 353–356.
3. Barel M, Fiandino A, Delcayre AX, Lyamani F, Frade R (1988) Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on gp 140, the EBV/C3dR expressed on human B lymphocytes. J. Immunol. 141: 1590–1595.
4. Barel M, Fiandino A, Lyamani L, Frade R (1989) Epstein-Barr virus/C3d receptor (EBV/C3dR) reacts with p53, a cellular anti-oncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti- EBV/C3dR antibodies (Ab2). Proc. Natl. Acad. Sei. USA. 86: 10054–10058.
5. Barel M, Gauffre A, Lyamani F, Fiandino-Tirel A, Hermann J, Frade R. (1991) Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium- binding protein present in normal but not in transformed B lymphocytes. J. Immunol. 147: 1286–1291.